Table 1 Patients’ characteristics

Total number of patients, n

114

Age, years, Median (Range)

70 (40-96)

Gender, male/female

95/19

Recurrence within 24 months, n (%)

38 (33.0)

pT Stage of first recurrence within 24 months

 pTa

25 (65.8)

 pT1

5 (13.1)

 ≥ pT2

3 (7.9)

 Cis

11 (28.9)

 G1

15 (39.5)

 G2

9 (23.6)

 G3

9 (23.6)

Interval between last bladder cancer episode and urine marker sampling, months, Median (Range)

6 (3-84)

pT/Grade last bladder cancer episode before urine marker sampling, n (%)

 pTa

74 (64.9)

 pT1

28 (24.5)

 Cis (pure)

12 (10.5)

 Cis (concomitant)

11 (9.6)

 G1

51 (44.7)

 G2

35 (30.1)

 G3

16 (14.0)

Highest pT/Grade in patient’s history before urine marker sampling, n (%)

 pTa

71 (62.3)

 pT1

32 (27.3)

 Cis (pure)

11 (9.6)

 Cis (concomitant)

16 (14.0)

 G1

47 (41.2)

 G2

39 (34.2)

 G3

17 (14.9)

Time to recurrence, months, Median (Range)

12.5 (3-24)

Patients developing progression, n (%)

13 (11.4)

Time to progression, months, Median (Range)

11 (3-24)